Published in Exp Parasitol on February 01, 1977
Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med (1982) 3.26
Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med (1983) 3.07
Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. Proc Natl Acad Sci U S A (1982) 1.82
Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. Bull World Health Organ (1990) 1.26
Characterization of sporozoite surface antigens by indirect immunofluorescence: detection of stage- and species-specific antimalarial antibodies. Bull World Health Organ (1979) 1.20
Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier. Infect Immun (1987) 1.02
Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor. Malar J (2004) 1.01
Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine (2015) 0.95
Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model. PLoS One (2010) 0.87
Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants. Am J Trop Med Hyg (2011) 0.85
Platform for Plasmodium vivax vaccine discovery and development. Mem Inst Oswaldo Cruz (2011) 0.81
In vitro cultivation of the sporogonic stages of Plasmodium: a review. Bull World Health Organ (1977) 0.79
Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects. Trends Parasitol (2016) 0.76
The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med (1976) 7.89
Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci (1973) 4.18
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (1987) 3.51
Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg (1975) 3.32
A quinoline methanol (WR 30090) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.85
Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrob Agents Chemother (1976) 2.71
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis (1997) 2.55
A phenanthrene methanol (WR 33063) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.05
Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci (1973) 1.84
Treatment of falciparum malaria caused by strain resistant to quinine. JAMA (1970) 1.81
Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine. Am J Trop Med Hyg (1977) 1.64
Prophylactic activity of a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090) in human malaria. Antimicrob Agents Chemother (1973) 1.57
Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ (1981) 1.47
Antimalarial effects of tetracyclines in man. J Trop Med Hyg (1971) 1.19
Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection. J Clin Microbiol (1989) 1.07
Prophylaxis of malaria in man using the sulfones DFD and DDS alone and with chloroquine. Mil Med (1971) 0.99
Drug resistance in the human malarias. Antibiot Chemother (1971) (1975) 0.94
Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy. Antimicrob Agents Chemother (1990) 0.93
Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteers. Am J Trop Med Hyg (1989) 0.91
Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites. Bull World Health Organ (1990) 0.89
Diformyl diaminodiphenyl sufone (DFD) as an antimalarial in man. Mil Med (1970) 0.87
Suppression of malaria in Tanzania with the use of medicated salt. Bull World Health Organ (1966) 0.87
A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines. Trop Geogr Med (1988) 0.86
Antimalarial effects of clindamycin in man. Am J Trop Med Hyg (1975) 0.85
Plasmodium falciparum: in vitro characterization and human infectivity of a cloned line. Exp Parasitol (1992) 0.85
Prophylaxis of malaria in man using the sulfone DFD with pyrimethamine. Mil Med (1973) 0.85
Drug resistance of malaria parasites in Tanzania. East Afr Med J (1966) 0.84
Resistance to chloroquine of Plasmodium falciparum from Burma. Trans R Soc Trop Med Hyg (1972) 0.84
Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3. Trans R Soc Trop Med Hyg (1990) 0.83
Sulfalene and trimethoprim in acute falciparum malaria. JAMA (1969) 0.83
Prophylactic and sporontocidal treatment of chloroquine resistant Plasmodium falciparum from Malaya. Trans R Soc Trop Med Hyg (1970) 0.83
Urinary neopterin in volunteers experimentally infected with Plasmodium falciparum. Trans R Soc Trop Med Hyg (1992) 0.83
Characterization of a drug resistant strain of Plasmodium falciparum from the Philippines. J Trop Med Hyg (1971) 0.82
Serum glycoproteins in experimentally induced malaria in man. J Lab Clin Med (1968) 0.82
Antimalarial effect of diaphenylsulfone and three sulfonamides among semi-immune Africans. Am J Trop Med Hyg (1967) 0.80
Prophylactic and sporontocidal treatment of chloroquine-resistant Plasmodium falciparum from Vietnam. Am J Trop Med Hyg (1971) 0.80
Characteristics of Plasmodium falciparum from the Solomon Islands. J Trop Med Hyg (1974) 0.80
Influence of sulfalene upon gametocytogenesis of Plasmodium falciparum and subsequent infection patterns in Anopheles stephensi. Exp Parasitol (1973) 0.80
Letter: Resistance to chloroquine of Plasmodium falciparum from Sabah. Trans R Soc Trop Med Hyg (1973) 0.79
Field trials of repository antimalarial compounds. J Trop Med Hyg (1969) 0.79
Characterization of a drug resistant strain of Plasmodium falciparum from Burma. J Trop Med Hyg (1973) 0.79
Characterisation of a drug resistant strain of Plasmodium falciparum from Sabah. J Trop Med Hyg (1973) 0.78
Malaria eradication in East Africa. East Afr Med J (1965) 0.78
Effects of ingested human anti-sporozoite sera on Plasmodium falciparum sporogony in Anopheles stephensi. Am J Trop Med Hyg (1993) 0.77
A modified leukocyte nitroblue tetrazolium test in acute bacterial infection. Am J Clin Pathol (1976) 0.77
Chloroquine-resistant falciparum malaria from Irian Jaya (Indonesian New Guinea). J Trop Med Hyg (1976) 0.77
Treatment of drug-resistant malaria in man. Bull World Health Organ (1974) 0.77
The problem of drug-resistant malaria. Am J Trop Med Hyg (1972) 0.76
Characteristics of four new drug-resistant strains of Plasmodium falciparum from South-East Asia. Mil Med (1969) 0.76
Comparative efficiency of Anopheles stephensi and Anopheles gambiae as vectors of drug-resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg (1974) 0.76
Responsibility for failure of sulphonamides in falciparum malaria; host or parasite? Trans R Soc Trop Med Hyg (1972) 0.75
Malaria in Maryland since 1960: incidence and research. Md Med J (1989) 0.75
Plasmodium falciparum: responses of a semi-immune individual to homologous and heterologous challenges, and non-infectivity of gametocytes in Anopheles stephensi. Am J Trop Med Hyg (1978) 0.75
Characterization and pathophysiology of serum glycoprotein alterations in malaria. J Lab Clin Med (1972) 0.75
The subgenus Persicargas (Ixodoidea, Argasidae, Argas). 2. A. (P.) abdussalami, new species, associated with wild birds on trees and buildings near Lahore, Pakistan. Ann Entomol Soc Am (1965) 0.75
Malaria distribution in Tanganyika. V. The north. East Afr Med J (1965) 0.75
Malaria distribution in Tanganyika. VI. Western Tanzania. East Afr Med J (1965) 0.75
Treatment of falciparum malaria with sulfalene and trimethoprim. Am J Trop Med Hyg (1971) 0.75
Treatment of multi-drug resistant malaria. East Afr Med J (1967) 0.75
Acetylator phenotype in sulphonamide resistant falciparum malaria. Ann Trop Med Parasitol (1974) 0.75